News & Events about Avrobio Inc.
AVROBIO, Inc. (NASDAQ:AVRO Get Rating) Investment analysts at Wedbush issued their Q1 2023 earnings per share estimates for AVROBIO in a report issued on Tuesday, May 10th. Wedbush analyst D. Nierengarten forecasts that the company will earn ($0.29) per share for the quarter. Wedbush...
Business Wire
9 months ago
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced that the company has granted a non-statutory stock option for the purchase of up to 63,000 shares of the companys common stock to one...
Ticker Report
10 months ago
Wall Street analysts predict that AVROBIO, Inc. (NASDAQ:AVRO Get Rating) will report earnings of ($0.71) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for AVROBIOs earnings, with estimates ranging from ($0.76) ...